Targeting polo-like kinase 1 by NMS-P937 in osteosarcoma cell lines inhibits tumor cell growth and partially overcomes drug resistance.
about
Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma CellsTargeting protein kinases to reverse multidrug resistance in sarcoma.Advances in emerging drugs for osteosarcoma.Doxorubicin-resistant osteosarcoma: novel therapeutic approaches in sight?Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics.MEK inhibition induces apoptosis in osteosarcoma cells with constitutive ERK1/2 phosphorylation.
P2860
Targeting polo-like kinase 1 by NMS-P937 in osteosarcoma cell lines inhibits tumor cell growth and partially overcomes drug resistance.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Targeting polo-like kinase 1 b ...... lly overcomes drug resistance.
@en
type
label
Targeting polo-like kinase 1 b ...... lly overcomes drug resistance.
@en
prefLabel
Targeting polo-like kinase 1 b ...... lly overcomes drug resistance.
@en
P2093
P2860
P50
P1476
Targeting polo-like kinase 1 b ...... lly overcomes drug resistance.
@en
P2093
Barbara Valsasina
Beth Gudeman
Elisa Tavanti
Francesca Michelacci
Marilù Fanelli
Serena Vella
Valeria Sero
P2860
P2888
P304
P356
10.1007/S10637-014-0158-6
P577
2014-09-07T00:00:00Z
P6179
1035561882